Sunshine Lake Pharma Co., Ltd.: Hepatitis C trials

The registry lists 10 Hepatitis C studies with Sunshine Lake Pharma Co., Ltd. as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 7Phase 2 3Phase 3 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis CCompletedNCT05395416Phase 2/3
• Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy SubjectsCompletedNCT04232514Phase 1
• The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected SubjectsCompletedNCT04202952Phase 1/2
• The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected SubjectsCompletedNCT04201275Phase 1
• The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult SubjectsCompletedNCT03903081Phase 1
• The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult SubjectsCompletedNCT03811678Phase 1
• The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult SubjectsCompletedNCT03673696Phase 1
• Phase 3 Study of Yimitasvir Phosphate CapsulesCompletedNCT03487107Phase 3
• The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults SubjectsCompletedNCT03462173Phase 1
• Phase 2 Study of Yimitasvir Phosphate CapsulesCompletedNCT03458481Phase 2